SALT LAKE CITY, May 31, 2019 /PRNewswire/ — Code, an innovator in healthcare automation and mobile technology, is shipping the market’s first fully-enclosed battery case for the iPhone 7 and 8. Designed for healthcare, the CR7000 mobile case is exclusively built with PVC-free CodeShield® disinfectant-ready plastics and Dragontrail™ glass. This completely sealed enclosure not only protects the iPhone from repeated chemical wipe downs, but promotes a higher level of patient safety, removing access for germs to hitch a ride from one patient room to another. It’s the ultimate protection.
According to the CDC, every day, one in 31 patients will contract an infectious disease during a hospital visit. Many of these are caused by strong bacteria that can lead to serious complications like sepsis, or even death1. Mobile technology at the point of care has historically been unable to stand up to strict cleaning and disinfecting processes. This meant devices would get damaged under chemical exposure, or worse, they weren’t being cleaned properly, contributing to the spread of infectious disease. The CR7018 solves this problem by protecting the mobile devices from damage while promoting easy, thorough disinfection.
“The CR7000 allows healthcare leaders to protect their investments but more importantly their patients,” said Jennifer Braun, Mobile Program Manager. “Healthcare facilities have been searching for an enterprise mobility solution that accommodates their workflows and meets infection control standards—they’re looking for the CR7000 product line.”
Over the past few years, hospitals have been making do with consumer grade cases to protect and provide power for their iPhones. Unfortunately, these cases do not fully envelop the phone, leading to difficult infection control and premature failure of the mobile devices. These cases also don’t have a swappable battery, so hospitals have been swapping the cases for a charged one, which has led to premature failure of the cases as well.
The CR7000 mobile series is designed explicitly for clinical workflows. The CodeShield plastics and Dragontrail™ glass screen protector provide confidence and durability; the fully enclosed housing safeguards against potentially harmful biomatter buildup; the quick-swap batteries and charging solutions provide 24/7 power and flexibility to keep your clinicians on the go; the BatteryTrak™ mobile application gives administrators visibility to the age of their batteries and helps them plan appropriately for replacements. There is no other mobile solution built specifically for clinicians like the CR7000.
“Health systems should be able to take full advantage of the benefits of mobile devices without having to sacrifice efficiency or infection control,” said George Powell, CEO and President of Code. “With the ruggedness and extra power of the CR7000, hospitals can recognize the full potential of a mobile workforce.”
About Code
Code is a technology leader in data capture solutions and mobile technology. Code designs and manufactures a complete line of hardware and software solutions to enhance productivity and exceed customers’ expectations for superior barcode reading performance, ergonomic design, equipment durability, and seamless integration with their operations. Servicing a diverse range of industries and environments, Code’s products are used in critical applications in healthcare, public safety, manufacturing, transportation, retail, and a range of other diverse industries.
Code’s worldwide headquarters are located in Salt Lake City, USA, with regional headquarters in the Netherlands. For more information, visit www.codecorp.com.
iPhone® is a registered trademark of Apple Inc.
DragontrailTM is a trademark of Asahi Glass, Limited.
1https://www.cdc.gov/hai/data/index.html; https://www.cdc.gov/winnablebattles/report/HAIs.html
Media Contact for Code:
Leslie Bryant, Marketing Manager
Email: Leslie.Bryant@codecorp.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/improve-patient-safety-with-codes-smart-battery-case-300859534.html
SOURCE Code
Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…
– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…
YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…
WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development…
TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or…